State Street
CGEM icon

State Street’s Cullinan Oncology CGEM Stock Holding History

State Street’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.2M Buy
2,544,115
+346,777
+16% +$4.46M ﹤0.01% 1922
2025
Q4 		$22.7M Buy
2,197,338
+520,024
+31% +$4.69M ﹤0.01% 2187
2025
Q3 		$9.95M Buy
1,677,314
+69,722
+4% +$511K ﹤0.01% 2645
2025
Q2 		$12.1M Sell
1,607,592
-145,087
-8% -$1.17M ﹤0.01% 2476
2025
Q1 		$13.3M Sell
1,752,679
-371,805
-18% -$3.57M ﹤0.01% 2356
2024
Q4 		$25.9M Sell
2,124,484
-212,738
-9% -$3.06M ﹤0.01% 2079
2024
Q3 		$39.1M Buy
2,337,222
+396,034
+20% +$7.02M ﹤0.01% 1828
2024
Q2 		$33.9M Buy
1,941,188
+515,729
+36% +$11M ﹤0.01% 1856
2024
Q1 		$24.3M Buy
1,425,459
+860,055
+152% +$13.3M ﹤0.01% 2100
2023
Q4 		$5.76M Buy
565,404
+43,508
+8% +$385K ﹤0.01% 2880
2023
Q3 		$4.72M Sell
521,896
-325
-0.1% -$3.38K ﹤0.01% 2945
2023
Q2 		$5.62M Sell
522,221
-39,993
-7% -$425K ﹤0.01% 2940
2023
Q1 		$5.75M Buy
562,214
+7,863
+1% +$86.7K ﹤0.01% 2939
2022
Q4 		$5.85M Buy
554,351
+52,835
+11% +$642K ﹤0.01% 2975
2022
Q3 		$6.43M Buy
501,516
+27,088
+6% +$365K ﹤0.01% 2938
2022
Q2 		$6.08M Sell
474,428
-607,109
-56% -$6.88M ﹤0.01% 2993
2022
Q1 		$11.3M Sell
1,081,537
-93,826
-8% -$1.27M ﹤0.01% 2755
2021
Q4 		$18.1M Buy
1,175,363
+812,404
+224% +$16.2M ﹤0.01% 2549
2021
Q3 		$8.19M Buy
362,959
+135,116
+59% +$3.61M ﹤0.01% 2990
2021
Q2 		$5.87M Buy
227,843
+33,028
+17% +$1.02M ﹤0.01% 3176
2021
Q1 		$8.12M Buy
+194,815
New +$7.91M ﹤0.01% 2836

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return